Antibody technology has acquired a lot of significance in modern-day healthcare sector and its advancement has, in turn, led to the development of diagnostic as well as therapeutic sciences. The development of monoclonal antibodies has been specially relevant as they can be produced against almost any type of antigen and production possibilities for such types of antigens is almost unlimited. Antibody technology has revolutionised healthcare by significantly increasing the life expectancy of patients. In India, there is a tremendous scope of expansion for the therapeutic as well as diagnostic antibodies markets, although diagnostic antibodies tend to dominate the overall market scenario. The diagnostic antibodies market has low entry barriers and is a very price-conscious segment. On the other hand, the market for therapeutic antibodies is still at a nascent stage of growth, but holds significant future potential. Hide this